Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

Cables1 Inhibitors

Cables1 inhibitors belong to a specific class of chemical compounds that have gained attention in the field of molecular biology and cell cycle regulation. Cables1, also known as CDK5 and ABL enzyme substrate 1 (Cables1), is a protein involved in the intricate control of the cell cycle and cellular proliferation. Proper regulation of the cell cycle is essential for maintaining genomic stability and preventing uncontrolled cell division, a hallmark of cancer. Cables1 acts as a critical mediator that restrains cell cycle progression by inhibiting the activity of Cyclin-dependent kinases (CDKs), including CDK2 and CDK1, which are key players in driving the cell cycle forward. Cables1 inhibitors are chemical compounds designed to interact with Cables1, potentially modulating its role in cell cycle regulation and influencing processes related to cell division and proliferation.

The mechanism of action of Cables1 inhibitors typically involves their binding to Cables1, often at specific binding sites or domains within the protein structure. This interaction can lead to changes in Cables1's ability to inhibit CDK activity, potentially affecting the progression of the cell cycle and cellular proliferation. Consequently, Cables1 inhibitors may have implications for various cellular processes, including the control of cell division, genomic integrity, and the prevention of uncontrolled cell growth. The study of Cables1 inhibitors is instrumental in advancing our understanding of cell cycle regulation, offering insights into the molecular mechanisms that govern the orderly progression of cells through the cell cycle. Additionally, it contributes to the broader field of cell biology and cancer research, providing valuable tools for investigating the roles of Cables1 in various cellular contexts and its impact on cellular proliferation and genomic stability.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Inhibits eukaryotic protein synthesis by interfering with the translocation step, potentially reducing Cables1 protein levels.

Bortezomib

179324-69-7sc-217785
sc-217785A
2.5 mg
25 mg
$132.00
$1064.00
115
(2)

Proteasome inhibitor that may increase cellular stress, potentially downregulating Cables1 expression.

Chloroquine

54-05-7sc-507304
250 mg
$68.00
2
(0)

Known to alter endosomal and lysosomal pH and might indirectly affect Cables1 mRNA stability or degradation.

Etoposide (VP-16)

33419-42-0sc-3512B
sc-3512
sc-3512A
10 mg
100 mg
500 mg
$32.00
$170.00
$385.00
63
(1)

Targets DNA topoisomerase II, potentially disrupting transcription factors and mRNA synthesis including Cables1.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Alkylating agent that can adduct DNA and may inhibit transcription, potentially affecting Cables1 expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Binds to DNA and can inhibit RNA polymerase, possibly leading to decreased Cables1 mRNA transcription.

Aphidicolin

38966-21-1sc-201535
sc-201535A
sc-201535B
1 mg
5 mg
25 mg
$82.00
$300.00
$1082.00
30
(3)

Inhibits DNA polymerase, which could result in reduced transcriptional activity, possibly affecting Cables1 expression.

Retinoic Acid, all trans

302-79-4sc-200898
sc-200898A
sc-200898B
sc-200898C
500 mg
5 g
10 g
100 g
$65.00
$319.00
$575.00
$998.00
28
(1)

A metabolite of Vitamin A that modulates gene expression and could potentially decrease Cables1 transcription.

5-Azacytidine

320-67-2sc-221003
500 mg
$280.00
4
(1)

A DNA methyltransferase inhibitor that can alter gene expression patterns, potentially affecting Cables1 expression.

Staurosporine

62996-74-1sc-3510
sc-3510A
sc-3510B
100 µg
1 mg
5 mg
$82.00
$150.00
$388.00
113
(4)

A potent kinase inhibitor that could affect multiple signaling pathways, possibly impacting Cables1 expression.